Cite
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.
MLA
Bogdanet, Delia, et al. “The Ability of PGCD59 to Predict Adverse Pregnancy Outcomes: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.” Acta Diabetologica, vol. 60, no. 2, Feb. 2023, pp. 211–23. EBSCOhost, https://doi.org/10.1007/s00592-022-01983-z.
APA
Bogdanet, D., Castillo, M. T., Doheny, H., Dervan, L., Luque-Fernandez, M. A., Halperin, J. A., O’Shea, P. M., & Dunne, F. P. (2023). The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland. Acta Diabetologica, 60(2), 211–223. https://doi.org/10.1007/s00592-022-01983-z
Chicago
Bogdanet, Delia, Michelle Toth Castillo, Helen Doheny, Louise Dervan, Miguel Angel Luque-Fernandez, Jose A. Halperin, Paula M. O’Shea, and Fidelma P. Dunne. 2023. “The Ability of PGCD59 to Predict Adverse Pregnancy Outcomes: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.” Acta Diabetologica 60 (2): 211–23. doi:10.1007/s00592-022-01983-z.